Crossmark

CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer

Crossref DOI link: https://doi.org/10.1186/s12957-016-1094-z

Published Online: 2017-01-28

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Si, Jiahui

Zhang, Panpan

Tian, Dan

Wang, Xing

Ma, Yuanyuan

Zhang, Jianzhi

Wang, Lu

Yang, Yue http://orcid.org/0000-0002-8886-7682
Funding

Funding for this research was provided by:

Beijing Municipal Administration of Hospitals Clinical Medicine Development Special Fund (ZYLX201509)

Peking University (PKU) 985 Special Fund for Collaborative Research with PKU Hospitals

National High Technology Research and the capital health research and development of special (2014-2-1021)